Intrinsiqs

Is Elicio Therapeutics, Inc. overvalued?

Elicio Therapeutics, Inc. (ELTX) — key valuation metrics and fundamentals.

No verdict
Price
$3.09
Fair value
Current P/E
Normal P/E
Market cap
$58.9M
Dividend yield
0.0%
Return on equity
-2748.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ELTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.